Rabeprazole vs esomeprazole in non-erosive gastro-esophageal reflux disease: A randomized, double-blind study in urban Asia

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 20

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

497

HTML

3678

Figures (1-3)

210

Tables (1-2)

201

Sum=4586

May 28, 2005 (publication date) through Nov 19, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Research

World J Gastroenterol. May 28, 2005; 11(20): 3091-3098
Published online May 28, 2005. doi: 10.3748/wjg.v11.i20.3091

Math 1 Math(A1).

Open in New Tab Full Size Figure Download Figure

Figure 1 Satisfactory relief of day-time heartburn and regurgitation (in patients who had both heartburn and regurgitation).

Figure 2 Change in symptom severity score from pre-treatment on d 1 to 5

Citation: Fock K, Teo E, Ang T, Chua T, Ng T, Tan Y. Rabeprazole vs esomeprazole in non-erosive gastro-esophageal reflux disease: A randomized, double-blind study in urban Asia. World J Gastroenterol 2005; 11(20): 3091-3098
URL: https://www.wjgnet.com/1007-9327/full/v11/i20/3091.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i20.3091